Pumps in the Pharmceutical Industry Up to the GMP–Challenge with AODD Pumps

How pumps help meeting the most stringent Good Manufacturing Practice Guidelines — When you’re working at the highest standards, your process equipment should be up the task. Special care has to given to process euqipment like pumps, when handling hazardous materials in demanding API production environments. Manufacturers need a technology that is 100 % reliable, safe and efficient. A technology like AODD pumps …

Related Vendors

Glatt Ingenieurtechnik GmbH

Maag Pump Systems AG

Donadon SDD Srl

ALMATEC Maschinenbau GmbH

The story of Lab Ofichem is an interesting example of how the movements of a highly regulated market can change the face of a company. Originally founded as “Laboratorium Oldenziel Fine Chemicals” in 1975, the company established itself as a successful family-operated developer, manufacturer and distributor of active pharmaceutical ingredients (API) for human and veterinary-medicine markets over the next few decades.

That began to change in the late 1990s when Europe and North America began mandating to incorporate Good Manufacturing Practices (GMP) in their operations, meaning they had to define how and under what conditions a product was manufactured.

While an admirable goal, the required use of GMPs had unintended consequences for many API producers, namely higher production and equipment costs, enabling India and China — which were not subject to the mandates of GMPs — to intrude on the global market.

Going Global

So, in 2006, founder Dr. O.H. Oldenziel made the decision to introduce the GMP guidelines into Ofichem’s operations. Oldenziel never got a chance to see the full blossoming of his vision, as he passed away in December 2006, but his legacy of innovation at Lab Ofichem, now part of a larger umbrella company (along with subsidiaries Ofipharma and Indopharm) known as the Ofichem Group, continues in both execution and name, as his and his wife and co–founder’s son, Weite Oldenziel, is now the group's General Director.

“In combining the knowledge of Lab Ofichem with the network of Ofichem and Indopharm we can help our customers more specifically with their questions and problems,” said Oldenziel. “We can also produce and analyze APIs, and have the facilities to be able to store a large amount of APIs in our own warehouse. In short, we have laid the foundation for a company that is ready for the future.”

That future already includes a global reach, with the Ofichem Group operating satellite sales offices in Barcelona, Spain; Hamburg, Germany; and Paris, France, while it having two offices in China, where a lot of product research and development is performed.

(ID:44162089)